Oxford Drug Design

Dr Michael Charlton presents at CCG’s European User Group Meeting

Dr Michael Charlton recently presented our work in designing novel aminoacyl tRNA synthetase inhibitors at the Chemical Computing Group’s European User Group meeting in Oxford.

Michael showed how we use CCG’s MOE modelling software in combination with our own ligand-based virtual screening methods to design novel inhibitors of leucyl tRNA synthetase.


Blue Boar Court
9 Alfred Street
Oxford OX1 4EH, UK

contactus@oxforddrugdesign.com
+44 (0)1865 261468

Quick Links
© Oxford Drug Design. All Rights Reserved 2023. Legal Information. Site Design by Koma.live